Supplemental Table 6 from Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors

Read full text Summarise with VIRAT
Authors: Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi, Shuta Tomida, Natsumi Iwawaki, Kei Kunimasa, Tomohiro Nakayama, Satomi Watanabe, Shinichiro Suzuki, Kazuko Sakai, Koichi Azuma, Keita Kudo
+5 more Kazuto Nishio, Kazuhiko Nakagawa, Hidetoshi Hayashi, Takeshi Teramura, Kimio Yonesaka
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Baseline clinical characteristics of 17 NSCLC patients treated with EGFR-TKIs and classified according to PTPRR mRNA abundance in pretreatment tumor specimens as determined by RNA-sequencing analysis.

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Protein Tyrosine Phosphatases HER2/EGFR in Cancer Research

Publication details

Publication date
2 April 2026
Language
EN